Claims for Patent: 6,977,257
✉ Email this page to a colleague
Summary for Patent: 6,977,257
| Title: | Aripiprazole oral solution |
| Abstract: | The present invention provides for a pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents and one or more agents selected from the group consisting of lactic acid, acetic acid, tartaric acid and citric acid, wherein said solution has a pH from 2.5 to 4.5. |
| Inventor(s): | Parab; Prakash V. (Monroe Township, NJ), Chou; Joyc Tianw i (Fremont, CA) |
| Assignee: | Bristol-Myers Squibb Company (Princeton, NJ) |
| Application Number: | 10/131,304 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,977,257 |
| Patent Claims: |
1. A pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system comprised of one or more agents selected from
the group consisting of water, ethanol, glycerin, propylene glycol and sorbitol, one or more taste-enhancing/masking agents and one or more other agents selected from the group consisting of lactic acid, acetic acid, tartaric acid and citric acid,
wherein said solution has a pH from 2.5 to 4.0.
2. A pharmaceutical solution according to claim 1 wherein said other agent is lactic acid. 3. A pharmaceutical solution according to claim 2 wherein said lactic acid is present at concentrations selected from the group of ranges consisting of 0.7 mg/ml to 18 mg/ml, 3.5 mg/ml to 14.5 mg/ml and 5.4 mg/ml to 9 mg. 4. A pharmaceutical solution according to claim 1 wherein aripiprazole is present at concentrations selected from the group of ranges consisting of 0.05 mg/ml to 6 mg/ml, 0.1 mg/ml to 3 mg/ml, 0.25 mg/ml to 2 mg/ml and 0.75 mg/ml to 1.5 mg/ml. 5. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of propylene glycol, glycerin and water each being present in ratios of 0.8-1.2:2.4-3.6:6.4-9.6 w/w respectively. 6. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin, propylene glycol and water each being present in ratios of 0.8-1.2:2.4-3.6:6.4-9.6 w/w respectively. 7. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin and water each being present in ratios of 0.8-1.2:6.4-8.6 w/w respectively. 8. A pharmaceutical solution according to claim 1 wherein said pharmaceutically suitable solvent system is comprised of glycerin and water each being present in ratios of about 1:3 w/w respectively. 9. A pharmaceutical solution according to claim 1 further comprising disodium EDTA. 10. A pharmaceutical solution suitable for oral administration comprising aripiprazole, a pharmaceutically suitable solvent system, one or more taste-enhancing/masking agents and lactic acid, wherein said solution has a pH from 2.5 to 4.5. 11. A pharmaceutical solution according to claim 10 wherein said pharmaceutically suitable solvent system is comprised of one or more agents selected from the group consisting of water, ethanol, glycerin, propylene glycol and sorbitol and wherein said solution has a pH from 2.5 to 4.0. 12. A pharmaceutical solution according to claim 11 wherein one or more of said taste-enhancing/masking agents are selected from the group consisting of flavoring agents, sucrose, fructose, dextrose, maltose, glucose, maltitol, xylitol, sorbitol and mannitol. 13. A pharmaceutical solution suitable for oral administration comprising aripiprazole, glycerin, lactic acid, propylene glycol, methylparaben, propylparaben, sucrose, fructose and water. |
